Elderly patients with DM who experience rapid progression, dysphagia, skin necrosis, leukocytoclastic vasculitis, and positive anti-p155 or anti-nuclear matrix protein-2 (NXP-2) antibodies are at a higher risk of developing neoplasms [45, 46]. Here, MORC3 is linked to dermatomyositis.